Abstract

Dr. Anupama Koneru*, Abul Khair Khan, Mohammed Safi Ur Rahman, Shaik Ibadullah, Syed Abdul Hadi Ghazanfar and Dr. Raghu C.

ABSTRACT

Coronary artery disease (CAD), which also include hypertension, stroke and valvular, muscular and congenital cardiac illness, is one of the diseases of cardiovascular disease (CVDs). In 1996, 29% of world deaths were due to CVD, which makes it the world's leading cause of death. Nearly half of those deaths are estimated by CAD. ? A wide range of diseases ranging from chronically stable angina to sudden myocardial infarction has long been recognised for coronary artery disease. Unstable angina, a diverse disease with widespread symptoms and prognostics is in the middle of this continuum. ? Angina contributes for around 1 million admissions to hospital every year 6 to8% of people suffering from this syndrome have or die within the first year following diagnosis of a nonfatal myocardial infarction. ? Identification and preventive efforts in industrialised countries have resulted in the identity of risk factors for CAD, i.e. diabetes, genetics, hypercholesterolemia and hypertensions. ? On the other hand, exposure to these risk factors in developing countries appears to be growing via "globalising" dietary patterns (PCR) in diabetic patients. The disease of the coronary artery is quite prevalent and costly. 1 Percutaneous coronary procedure (PCI, including balloon angioplasty) is used in addition to medical therapy in the treatment of symptomatic coronary artery disease, in addition to stent implantation and adjunctive technique such as thrombectomy and atherectomy. ? PCI is a choice treatment for the two major coronary artery disease sub-sets of high risk ACS, including ST myocardial elevation infarction (STEMI), NST myocardial elevation (NSTEMI), unstable angina(UA), and optimised guideline- orientated medical treatment for stable, symptomatic ischemic heart disease. PCI is also a treatment for the following major coronary artery disease.